Business Context and Reporting Period
Company: Natural Alternatives International, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 1998 (Third Quarter of Fiscal Year 1998)
Business Overview: The Company operates in the health and wellness sector, with significant revenue derived from multi-level distribution and retail channels. Operations include wholly-owned subsidiaries such as Millennium Health International, Inc. and CellLife International, Inc.
Key Financial Metrics
| Metric | Three Months Ended Mar 31, 1998 |
Nine Months Ended Mar 31, 1998 |
Three Months Ended Mar 31, 1997 |
Nine Months Ended Mar 31, 1997 |
|---|---|---|---|---|
| Net Sales | $18,960,255 | $47,290,172 | $11,406,325 | $35,473,581 |
| Gross Profit | $5,223,250 | $12,827,165 | $2,866,067 | $9,342,661 |
| Gross Margin % | 27.5% | 27.1% | 25.1% | 26.3% |
| Net Earnings | $1,823,729 | $3,785,172 | $560,637 | $2,310,302 |
| Diluted EPS | $0.31 | $0.66 | $0.10 | $0.41 |
| Cash & Equivalents | $3,399,360 (as of Mar 31, 1998) | |||
| Working Capital | $16,273,000 (as of Mar 31, 1998) | |||
| Total Debt (Current + Long-term) | $1,065,130 (as of Mar 31, 1998) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 66% for the quarter and 33% for the nine-month period compared to the prior year. Approximately two-thirds of the quarterly increase and three-fourths of the nine-month increase were attributed to new customers.
- International Expansion: International sales surged to $2.6 million for the quarter (from $0.5 million) and $10.6 million for the nine months (from $1.3 million), driven by existing customers expanding into foreign markets.
- Profitability: Net earnings rose 225% for the quarter and 64% for the nine months. Gross margins improved due to purchasing and manufacturing cost efficiencies.
- Operating Expenses: Selling, general, and administrative (SG&A) expenses increased in absolute dollars but decreased as a percentage of revenue (from 17.0% to 11.9% for the quarter) due to sales volume leverage. Increases in SG&A were partially driven by a new employee pension plan and R&D costs.
- Cash Flow: Net cash provided by operating activities decreased to $1.44 million for the nine months ended March 31, 1998, compared to $2.78 million in the prior year, primarily due to significant increases in accounts receivable and inventory levels.
Outlook, Risks, and Management Commentary
- Liquidity: The Company maintains a revolving line of credit of up to $3,000,000 secured by receivables, inventory, and equipment. No borrowings were outstanding under this line as of March 31, 1998. Management believes internal cash flow and credit facilities are sufficient to fund operations and capital expenditures.
- Capital Expenditures: The Company has purchase commitments of approximately $450,000 for production equipment expected to be placed in service in the fourth quarter.
- Customer Concentration Risk: Five customers accounted for 65% of sales in the quarter and 56% of sales for the nine-month period. The loss of any of these customers could materially impact revenues.
- Legal Proceedings: The Company is involved in various ordinary course legal actions, which management does not expect to have a material adverse impact.
- Forward-Looking Statements: Management cautions that actual results may differ from projections due to risks discussed in the Form 10-K.
Investor Verification Checklist
- Customer Concentration: Verify the stability of the top five customers, who represent over half of total sales.
- Working Capital Efficiency: Monitor the trend of Accounts Receivable and Inventory, which increased significantly and reduced operating cash flow despite higher earnings.
- International Sales Sustainability: Assess the durability of the rapid growth in international sales driven by existing customers.
- Debt Covenants: Review the terms of the $3,000,000 revolving credit line and any potential covenants related to the increase in inventory and receivables.
- Pension Plan Impact: Evaluate the long-term financial impact of the defined benefit pension plan adopted in January 1997.